INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2013
Total net assets |
£159.1m |
NAV per share |
288.4p |
Share price |
254.0p |
Total value of unquoted investments |
£25.5m |
Total number of portfolio companies |
68 |
Cash |
1% NAV |
Cash committed and reserved to unquoted investments |
(5.7%) NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Gilead Celgene |
6.9 6.7 5.9 |
Alexion |
5.3 |
Biogen |
5.2 |
Regeneron |
5.0 |
Onyx |
4.3 |
Aptiv |
3.7 |
Vertex |
3.2 |
Incyte |
3.0 |
|
----------- |
Total |
49.2 |
Geographical Allocation |
% |
United States & Canada |
91 |
Europe |
8 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
82 |
Unquoted |
17 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JULY 2013